Following the concept of precision medicine, assessing Plin2 levels will allow for the stratification of tumor responsiveness to specific mitosis‐targeting drugs, including future Trip13 inhibitors as well as clinically established drugs such as paclitaxel. The gene discussed is TRIP13; the disease is neoplasm.